All News
|
News Release
Findings reveal tripling of blood levels of TMAO from red meat diet, but dietary effects can be reversed Researchers have identified another reason to limit red meat consumption: high levels of a gut-generated chemical called trimethylamine N-oxide (TMAO), that also is linked to heart disease. Scientists found that people who eat a diet rich in red...
|
NHLBI in the Press
In a study partly funded by NHLBI, a team of researchers found a 25 percent reduction in the risk of cardiovascular disease among participants who consumed a Mediterranean-type diet rich in plants and olive oil and low in meats and sweets.
|
NHLBI in the Press
Researchers have discovered a new link between atrial fibrillation (Afib)—a potentially life-threatening condition that causes rapid, irregular heartbeat—and mutations in a gene associated with heart disease.
|
News Release
Findings reveal tripling of blood levels of TMAO from red meat diet, but dietary effects can be reversed Researchers have identified another reason to limit red meat consumption: high levels of a gut-generated chemical called trimethylamine N-oxide (TMAO), that also is linked to heart disease. Scientists found that people who eat a diet rich in red...
|
News Release
Treatment of sleep disorder might help improve blood pressure control in this high-risk group African-Americans with moderate or severe sleep apnea are twice as likely to have hard-to-control high blood pressure when their sleep apnea goes untreated, according to a new study funded mainly by the National Heart, Lung, and Blood Institute (NHLBI), pa...
|
NHLBI in the Press
A team of NHLBI-funded scientists have cut out a segment of cells’ genomes that is the main reason for an increased risk of cardiovascular diseases, which include heart attacks, aneurysms or strokes, according to a study published in Cell.
|
Media Availability
WHAT: A scientist from the National Institutes of Health will present promising, early results from a human clinical trial testing a novel gene replacement therapy in people with severe sickle cell disease. Preliminary findings suggest that the approach has an acceptable level of safety and might help patients consistently produce normal red blood...
Credit: Jill George, NIH
|
NHLBI in the Press
An NHLBI researcher shared encouraging results from a human clinical trial testing a novel gene replacement therapy in people with severe sickle cell disease.
|
NHLBI in the Press
Researchers funded by NHLBI established that rotating night shift work combined with an unhealthy lifestyle significantly increase the risk of type 2 diabetes in women.
|
NHLBI in the Press
A daily hydroxyurea pill has proven safe and effective for young children living with sickle cell disease in sub-Saharan Africa, where the condition is far more prevalent.
|
Statement
On November 21, World COPD Day 2018, the National Institutes of Health unites with millions of people to renew our long-standing commitment to reducing the burden of chronic obstructive pulmonary disease ( COPD ), a serious and debilitating lung disease. A leading cause of death, COPD impacts an estimated 251 million people worldwide . While many h...